Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy

Ann Oncol. 2010 Jan;21(1):189-90. doi: 10.1093/annonc/mdp513. Epub 2009 Nov 4.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / therapeutic use*
  • Antineoplastic Agents / adverse effects*
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Dexamethasone / therapeutic use*
  • Exanthema / chemically induced
  • Exanthema / prevention & control*
  • Female
  • Gemcitabine
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy
  • Premedication / methods*
  • Secondary Prevention

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Deoxycytidine
  • Dexamethasone
  • Gemcitabine